You are here
Screening for Ovarian Cancer Continues, Despite Recommendations to the Contrary
February 7, 2012
Although the results don't necessarily translate into real practice, that means more than a million women might be offered the tests, which come with a hefty price tag and possible hazards, researchers say.
"Currently the evidence suggests that the harms of ovarian cancer screening exceed the benefits," said Dr. Laura-Mae Baldwin of the University of Washington in Seattle.
"That's why it is not being recommended."
Read the full article on Reuters.
Despite older, sicker patients, mortality rate fell by a third in 10 years
Study finds fewer than half of trials followed the law
WHO to meet tomorrow to decide on international public heath emergency declaration
Study of posted prices finds wild variations and missing data
Potential contamination could lead to supply chain disruptions
Kinase inhibitor targets tumors with a PDGFRA exon 18 mutation
Delayed surgery reduces benefits; premature surgery raises risks
Mortality nearly doubled when patients stopped using their drugs
Acasti reports disappointing results for a second Omega-3-based drug